Tilmann Bochtler
Impact in
- Hematology top 2%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 26
- Oncology 37
- Cancer Diagnosis and Treatment 25
- Co-authors
- Anthony D. Ho (30 shared papers)Ute Hegenbart (26 shared papers)Stefan Schönland (24 shared papers)Alwin Krämer (28 shared papers)Anna Jauch (20 shared papers)Axel Benner (18 shared papers)Hartmut Goldschmidt (17 shared papers)Dirk Hose (12 shared papers)
- Journals
- Blood (22 papers)Annals of Oncology (9 papers)Haematologica (5 papers)Leukemia (4 papers)Journal of Clinical Oncology (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Tilmann Bochtler
69 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 68
- Hematology 537
- Genetics 367
- Nephrology 143
- Oncology 533
- Molecular Biology 1.2k
Countries citing papers authored by Tilmann Bochtler
This map shows the geographic impact of Tilmann Bochtler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tilmann Bochtler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tilmann Bochtler more than expected).
Fields of papers citing papers by Tilmann Bochtler
This network shows the impact of papers produced by Tilmann Bochtler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tilmann Bochtler. The network helps show where Tilmann Bochtler may publish in the future.
Co-authors
The 25 scholars most cited alongside Tilmann Bochtler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 77 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 186 | |
| 2 | 2015 | 156 | |
| 3 | 2017 | 93 | |
| 4 | 2008 | 82 | |
| 5 | 2022 | 82 | |
| 6 | 2016 | 71 | |
| 7 | 2014 | 69 | |
| 8 | 2010 | 67 | |
| 9 | 2007 | 60 | |
| 10 | 2013 | 57 | |
| 11 | 2016 | 56 | |
| 12 | 2008 | 56 | |
| 13 | 2011 | 55 | |
| 14 | 2017 | 51 | |
| 15 | 2014 | 49 | |
| 16 | 2019 | 40 | |
| 17 | 2021 | 39 | |
| 18 | 2019 | 38 | |
| 19 | 2017 | 37 | |
| 20 | 2019 | 33 |
About Tilmann Bochtler
Tilmann Bochtler is a scholar working on Molecular Biology, Oncology, Hematology, Genetics and Oral Surgery, having authored 77 papers that have together received 1.8k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (26 papers), Cancer Diagnosis and Treatment (25 papers), Acute Myeloid Leukemia Research (16 papers), Oral and Maxillofacial Pathology (9 papers), Cancer Genomics and Diagnostics (8 papers), Tumors and Oncological Cases (8 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (7 papers) and Multiple Myeloma Research and Treatments (6 papers). The work is most often cited by research in Hematology (537 citations), Genetics (367 citations), Nephrology (143 citations), Oncology (533 citations) and Molecular Biology (1.2k citations). Tilmann Bochtler has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Anthony D. Ho, Ute Hegenbart, Stefan Schönland, Alwin Krämer, Anna Jauch, Axel Benner, Hartmut Goldschmidt, Dirk Hose, Christoph Kimmich and Martin Granzow. Their work appears in journals such as Blood, Annals of Oncology, Haematologica, Leukemia and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.